PT  - JOURNAL ARTICLE
AU  - Claire E Raphael
TI  - Renal denervation: potential indications and review of trial data
AID  - 10.7861/clinmedicine.14-6-s38
DP  - 2014 Dec 01
TA  - Clinical Medicine
PG  - s38--s40
VI  - 14
IP  - Suppl 6
4099  - http://www.rcpjournals.org/content/14/Suppl_6/s38.short
4100  - http://www.rcpjournals.org/content/14/Suppl_6/s38.full
SO  - Clin Med2014 Dec 01; 14
AB  - Renal sympathetic denervation is a novel, endovascular treatment with potential utility in resistant hypertension. First pioneered in humans in 2010, conflicting data exist regarding the efficacy of this treatment. This article will review the evidence to date, the scientific rationale for sympathetic denervation as a treatment for hypertension and consider other possible conditions where the therapy may be of benefit.